Data period: Mar 23-Feb 24

Analysis by Galen and IQVIA based on NHS Prescribing Data

The comparable preparation of Zemtard XL® is assumed in each case as the closest strength to each comparator e.g. Zemtard XL® 120mg vs. Adizem XL® 120mg. This is not intended to imply bioequivalence.

Percentage saving for Thorens® 10,000 I.U./ml oral drops is based on its maximum daily doses vs. those of Fultium-D3 drops, for the treatment of deficiency.

Percentage saving for Thorens® 25,000 I.U./2.5ml oral solution is based on the price of a 4-pack, and on an adult weekly dose (50,000 I.U.) vs. the maximum adult weekly dose of Fultium-D3 800 I.U. Capsules (22,400 I.U.), taken for the respective treatment lengths needed to achieve up to a total of approximately 300,000 I.U.

A percentage pack split has been applied to extract the relevant competitor pack sizes^† from the total cash sales, and the percentage savings available have been calculated versus the equivalent pack sizes of the Trustsaver products, based on list prices.

^† We have not provided cost savings versus all available pack sizes.

Adizem-XL® is a registered trademark of Mundipharma.

Fultium-D3 Drops is a registered trademark of Internis Pharmaceuticals Ltd.

Fultium-D3 800 I.U. Capsules is a registered trademark of Internis Pharmaceuticals Ltd.